Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

Social Neuroscience

Volumn 4, Issue 4, 2009, Pages 359-366

  Dumont, G J H ^a   Sweep, F C G J ^a   van der Steen, R ^a   Hermsen, R ^a   Donders, A R T ^a   Touw, D J ^b   van Gerven, J M A ^c   Buitelaar, J K ^a   Verkes, R J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Hematology   (Netherlands)

^c CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

Ecstasy; Human; MDMA; Oxytocin; Social cognition

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; OXYTOCIN; PLACEBO;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; RADIOIMMUNOASSAY; SOCIAL BEHAVIOR; SOCIAL INTERACTION; VOLUNTEER;

ADOLESCENT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HALLUCINOGENS; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXYTOCIN; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 68449091985     PISSN: 17470919     EISSN: 17470927     Source Type: Journal    
DOI: 10.1080/17470910802649470     Document Type: Article

References (39)

1. Adolphs, R. (2003). Cognitive neuroscience of human social behaviour. Nature Reviews Neuroscience, 4, 165-178.
2. Amaral, D. G., Bauman, M. D., Capitanio, J. P., Lavenex, P., Mason, W. A., Mauldin-Jourdain, M. L., et al. (2003). The amygdala: Is it an essential component of the neural network for social cognition? Neuropsychologia, 41, 517-522.
3. Amico, J. A., Tenicela, R., Johnston, J., & Robinson, A. G. (1983). A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans. Journal of Clinical Endocrinology and Metabolism 57, 947-951.
4. Armstrong, W. E. (2007). The neurophysiology of neurosecretory cells. Journal of Physiology, 585, 645-647.
5. Baumgartner, T., Heinrichs, M., Vonlanthen, A., Fischbacher, U., & Fehr, E. (2008). Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron, 58, 639-650.
6. Bond, A. J., James, D. C., & Lader, M. H. (1974). Physiological and psychological measures in anxious patients. Psychological Medicine 4, 364-373.
7. Campbell, A. (2008). Attachment, aggression and affiliation: The role of oxytocin in female social behavior. Biological Psychology, 77 1-10.
8. Chini, B., & Manning, M. (2007). Agonist selectivity in the oxytocin/ vasopressin receptor family: New insights and challenges. Biochemical Society Transactions, 35, 737-741.
9. Cornish, J. L., Shahnawaz, Z., Thompson, M. R., Wong, S., Morley, K. C., Hunt, G. E., et al. (2003). Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. European Journal of Pharmacology, 482, 339-341.
10. Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007). Oxytocin improves "mindreading" in humans. Biological Psychiatry, 61, 731-733.
11. Dumont, G. J., & Verkes, R. J. (2006). A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. Journal of Psychopharmacology, 20, 176-187.
12. Dumont, G. J., Wezenberg, E., Valkenberg, M. M., de Jong, C. A., Buitelaar, J. K., van Gerven, J. M., et al. (2008). Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers. Psychopharmacology (Berl.), 197, 465-474.
13. First, M. B., Frances, A. J., Pincus, H. A., Vettorello, N., & Davis, W. W. (1994). DSM-IV in progress: Changes in substance-related, schizophrenic, and other primarily adult disorders. Hospital and Community Psychiatry, 45, 18-20.
14. Gimpl, G., & Fahrenholz, F. (2001). The oxytocin receptor system: Structure, function, and regulation. Physiological Reviews, 81 629-683.
15. Guastella, A. J., Mitchell, P. B., & Dadds, M. R. (2008). Oxytocin increases gaze to the eye region of human faces. Biological Psychiatry, 63, 3-5.
16. Hammock, E. A., & Young, L. J. (2006). Oxytocin, vasopressin and pair bonding: Implications for autism. Philosophical Transactions of the Royal Society of London B: Biological Sciences, 361, 2187-2198.
17. Hargreaves, G. A., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2007). High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner. Neuroscience, 145, 764-774.
18. Huber, D., Veinante, P., & Stoop, R. (2005). Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308, 245-248.
19. Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., et al. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience, 25, 11489-11493.
20. Landgraf, R., & Neumann, I. D. (2004). Vasopressin and oxytocin release within the brain: A dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers in Neuroendocrinology, 25 150-176.
21. Lerer, E., Levi, S., Salomon, S., Darvasi, A., Yirmiya, N., & Ebstein, R. P. (2008). Association between the oxytocin receptor (OXTR) gene and autism: Relationship to Vineland Adaptive Behavior Scales and cognition. Molecular Psychiatry, 13, 980-988.
22. Lim, M. M., & Young, L. J. (2006). Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Hormones and Behavior, 50, 506-517.
23. Ludwig, M., & Leng, G. (2006). Dendritic peptide release and peptide-dependent behaviours. Nature Reviews Neuroscience, 7 126-136.
24. McNamara, I. M., Borella, A. W., Bialowas, L. A., & Whitaker-Azmitia, P. M. (2008). Further studies in the developmental hyperserotonemia model (DHS) of autism: Social, behavioral and peptide changes. Brain Research, 16, 203-214.
25. Nichols, D. E., & Oberlender, R. (1990). Structure- activity relationships of MDMA and related compounds: A new class of psychoactive drugs? Annals of the New York Academy of Sciences, 600, 613-623.
26. Parrott, A. C. (2007). The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): An evidence-based review. Psychopharmacology (Berl.), 191, 181-193.
27. Rosen, J. B., & Donley, M. P. (2006). Animal studies of amygdala function in fear and uncertainty: Relevance to human research. Biological Psychology, 73, 49-60.
28. Sanfey, A. G. (2007). Social decision-making: Insights from game theory and neuroscience. Science, 318, 598-602.
29. Sessa, B. (2007). Is there a case for MDMA-assisted psychotherapy in the UK? Journal of Psychopharmacology, 21, 220-224.
30. Sessa, B., & Nutt, D. J. (2007). MDMA, politics and medical research: Have we thrown the baby out with the bathwater? Journal of Psychopharmacology, 21, 787-791.
31. Svrakic, D. M., Whitehead, C., Przybeck, T. R., & Cloninger, C. R. (1993). Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Archives of General Psychiatry, 50, 991-999.
32. Talarovicova, A., Krskova, L., & Kiss, A. (2007). Some assessments of the amygdala role in suprahypothalamic neuroendocrine regulation: A minireview. Endocrine Regulations, 41, 155-162.
33. Thompson, M. R., Callaghan, P. D., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2007). A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience, 146, 509-514.
34. Uvnas-Moberg, K., Bruzelius, G., Alster, P., & Lundeberg, T. (1993). The antinociceptive effect of nonnoxious sensory stimulation is mediated partly through oxytocinergic mechanisms. Acta Physiologica Scandinavica, 149, 199-204.
35. Vollenweider, F. X., Liechti, M. E., Gamma, A., Greer, G., & Geyer, M. (2002). Acute psychological and neurophysiological effects of MDMA in humans. Journal of Psychoactive Drugs, 34, 171-184.
36. Winstock, A. R., Griffiths, P., & Stewart, D. (2001). Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug and Alcohol Dependence, 64, 9-17.
37. Wolff, K., Tsapakis, E. M.,Winstock, A. R., Hartley, D., Holt, D., Forsling, M. L., et al. (2006). Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. Journal of Psychopharmacology, 20, 400-410.
38. Young, L. J. (2002). The neurobiology of social recognition, approach, and avoidance. Biological Psychiatry, 51, 18-26.
39. Zak, P. J., Stanton, A. A., & Ahmadi, S. (2007). Oxytocin increases generosity in humans. Public Library of Science ONE, 2, e1128.